Abstract
The microbiome is the inherited substance of the numerous microscopic organisms that exist on and within the human body, including bacteria, protozoa, fungi, and viruses. The human gut microbiota is dominatingly made out of four groups of microbial phyla: Firmicutes, Bacteroides, Actinobacteria, and Proteobacteria; this entire microbiome assumes a significant job to the improvement of immunity. However, disruption of this homeostatic host–microorganism relationship can promote disease pathogenesis, such as in autoimmune diseases and cancer. Current investigations additionally show with the intention of the gut microbiome might influence the reaction to cancer treatment, by balancing the host cell inflammatory reaction. As the investigation of the microbiome is growing, various endeavors are being prepared to incline the range on the “ideal” microbiome region. In this regard, this chapter extensively discusses various types of cancers and the role of the microbiome in their treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander JL, Wilson ID et al (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 14(6):356–365
Arpaia N, Campbell C et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451–455
Aviles-Jimenez F, Vazquez-Jimenez F et al (2014) Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 4:4202
Backhed F, Manchester JK et al (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104(3):979–984
Beaulieu JF (2020) Colorectal Cancer research: basic, preclinical, and clinical approaches. Cancers 12(2):416
Bouskra D, Brezillon C et al (2008) Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456(7221):507–510
Bray F, Ferlay J et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Bullman S, Pedamallu CS et al (2017) Analysis of fusobacterium persistence and antibiotic response in colorectal cancer. Science 358(6369):1443–1448
Bultman SJ (2014) Emerging roles of the microbiome in cancer. Carcinogenesis 35(2):249–255
Burgess SL, Buonomo E et al (2014) Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis. mBio 5(6):e01817
Camilo V, Sugiyama T, Touati E (2017) Pathogenesis of helicobacter pylori infection. Helicobacter 22(Suppl 1):e12405
Cogdill AP, Gaudreau PO et al (2018) The impact of Intratumoral and gastrointestinal microbiota on systemic Cancer therapy. Trends Immunol 39(11):900–920
Curtis MM, Hu Z et al (2014) The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16(6):759–769
de Martel C, Ferlay J et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13(6):607–615
Deriu E, Liu JZ et al (2013) Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14(1):26–37
Dominguez-Bello MG, Godoy-Vitorino F et al (2019) Role of the microbiome in human development. Gut 68(6):1108–1114
Frank DN, Amand ALS et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104(34):13780–13785
Fukuda S, Toh H et al (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469(7331):543–547
Geva-Zatorsky N, Sefik E et al (2017) Mining the human gut microbiota for immunomodulatory organisms. Cell 168(5):928–943
Ghiringhelli F, Menard C et al (2007) Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 56(5):641–648
Gielda LM, Dirita VJ (2012) Zinc competition among the intestinal microbiota. mBio 3(4):e00171–e00112
Goedert JJ, Jones G et al (2015) Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst 107(8):djv147
Gorjifard S, Goldszmid RS (2016) Microbiota-myeloid cell crosstalk beyond the gut. J Leukoc Biol 100(5):865–879
Herp S, Brugiroux S et al (2019) Mucispirillum schaedleri antagonizes Salmonella virulence to protect mice against colitis. Cell Host Microbe 25(5):681–694
Hooper LV, Wong MH et al (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291(5505):881–884
Iida N, Dzutsev A et al (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342(6161):967–970
Jakobsson HE, Jernberg C et al (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 5(3):e9836
Jenq RR, Ubeda C et al (2012) Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 209(5):903–911
Johansson ME, Jakobsson HE et al (2015) Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe 18(5):582–592
Karin M, Jobin C et al (2014) Chemotherapy, immunity and microbiota--a new triumvirate? Nat Med 20(2):126–127
Lecuyer E, Rakotobe S et al (2014) Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses. Immunity 40(4):608–620
Lepage P, Leclerc MC et al (2013) A metagenomic insight into our gut's microbiome. Gut 62(1):146–158
Litvak Y, Mon KKZ et al (2019) Commensal Enterobacteriaceae protect against Salmonella colonization through oxygen competition. Cell Host Microbe 25(1):128–139
Luo GG, Ou JH (2015) Oncogenic viruses and cancer. Virol Sin 30(2):83–84
Lupp C, Skipper M et al (2012) Gut microbes and health. Nature 489(7415):219
Martins HM, Almeida I et al (2008) Interaction of wild strains of aspergilla with Aspergillus parasiticus ATCC15517 and aflatoxin production. Int J Mol Sci 9(3):394–400
Mathewson ND, Jenq R et al (2016) Corrigendum: gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 17(10):1235
McFall-Ngai MJ, Ruby EG (1991) Symbiont recognition and subsequent morphogenesis as early events in an animal-bacterial mutualism. Science 254(5037):1491–1494
Mitsuhashi K, Nosho K et al (2015) Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6(9):7209–7220
Morgan XC, Huttenhower C (2012) Chapter 12: human microbiome analysis. PLoS Comput Biol 8(12):e1002808
Pabst O (2012) New concepts in the generation and functions of IgA. Nat Rev Immunol 12(12):821–832
Paulos CM, Wrzesinski C et al (2007) Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest 117(8):2197–2204
Rajagopala SV, Yooseph S et al (2016) Gastrointestinal microbial populations can distinguish pediatric and adolescent acute lymphoblastic leukemia (ALL) at the time of disease diagnosis. BMC Genomics 17(1):635
Ramirez-Garcia A, Gallot N et al (2011) Molecular fractionation and characterization of a Candida albicans fraction that increases tumor cell adhesion to hepatic endothelium. Appl Microbiol Biotechnol 92(1):133–145
Ren Z, Jiang J et al (2017) Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget 8(56):95176–95191
Rosshart SP, Vassallo BG et al (2017) Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell 171(5):1015–1028
Routy B, Gopalakrishnan V et al (2018) The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol 15(6):382–396
Schirmer M, Smeekens SP et al (2016) Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167(7):1897
Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13(11):800–812
Sender R, Fuchs S et al (2016) Revised estimates for the number of human and Bacteria cells in the body. PLoS Biol 14(8):e1002533
Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350:1084–1089
Smith K, McCoy KD et al (2007) Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 19(2):59–69
Spiljar M, Merkler D et al (2017) The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front Immunol 8:1353
Tai E, Richardson LC et al (2011) Clostridium difficile infection among children with cancer. Pediatr Infect Dis J 30(7):610–612
Tan J, McKenzie C et al (2014) The role of short-chain fatty acids in health and disease. Adv Immunol 121:91–119
Ter Horst R, Jaeger M et al (2016) Host and environmental factors influencing individual human cytokine responses. Cell 167(4):1111–1124
Thomas H (2017) Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma. Nat Rev Gastroenterol Hepatol 14(11):632
Tomasello G, Mazzola M et al (2016) Nutrition, oxidative stress and intestinal dysbiosis: influence of diet on gut microbiota in inflammatory bowel diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 160(4):461–466
Urbaniak C, Gloor GB et al (2016) The microbiota of breast tissue and its association with breast Cancer. Appl Environ Microbiol 82(16):5039–5048
Uribe-Herranz M, Bittinger K et al (2018) Gut microbiota modulates adoptive cell therapy via CD8alpha dendritic cells and IL-12. JCI Insight 3(4):e94952
Vetizou M, Pitt JM et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350(6264):1079–1084
Viaud S, Saccheri F et al (2013) The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342(6161):971–976
Wang Y, Xue J et al (2014) Oral microbiota distinguishes acute lymphoblastic leukemia pediatric hosts from healthy populations. PLoS One 9(7):e102116
Xu S, Yin W et al (2020) Foes or friends? Bacteria enriched in the tumor microenvironment of colorectal Cancer. Cancers 12(2):372
Yi M, Jiao D et al (2018) Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors. Mol Cancer 17(1):129
Zambirinis CP, Pushalkar S et al (2014) Pancreatic cancer, inflammation, and microbiome. Cancer J 20(3):195–202
Zitvogel L, Daillere R et al (2017) Anticancer effects of the microbiome and its products. Nat Rev Microbiol 15(8):465–478
Acknowledgements
The authors are grateful to their respective academic institutions for the support extended.
Conflict of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Godisela, K.K., Kiran, B.S.S., Bramhachari, P.V. (2021). Cancer Microbiome and Immunotherapy: Understanding the Complex Responses Between Microbes, Immunity, and Cancer. In: Bramhachari, P.V. (eds) Microbiome in Human Health and Disease. Springer, Singapore. https://doi.org/10.1007/978-981-16-3156-6_6
Download citation
DOI: https://doi.org/10.1007/978-981-16-3156-6_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-3155-9
Online ISBN: 978-981-16-3156-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)